Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Clinical Evaluation of the Infinity Deep Brain Stimulation System

ClinicalTrials.gov ID: NCT02989610

Public ClinicalTrials.gov record NCT02989610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 4:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this post-market study is to characterize the clinical performance of the Infinity Deep Brain Stimulation (DBS) system, including the Implantable Pulse Generator (IPG), directional DBS leads, extensions, iPad clinician programmer, iPod patient controller and related system components. Participants in the PROGRESS study are not assigned to interventional therapy groups. Participants in the PROGRESS study are followed in an observational format as they receive omnidirectional and then directional DBS programming that is part of routine medical care. Data on symptoms are collected during two different stages of programming, and those outcomes compared to assess the effect of omnidirectional or directional programming.

Study identification

NCT ID
NCT02989610
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
234 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 30, 2017
Primary completion
Aug 6, 2019
Completion
Apr 18, 2022
Last update posted
Aug 21, 2024

2017 – 2022

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Kaiser Permanente Sacramento Medical Center Sacramento California 95825
University of Colorado Hospital Aurora Colorado 80045
Shands at University of Florida Gainesville Florida 32610
University of Miami Hospital Miami Florida 33136
Rush University, Department of Neurological Sciences Chicago Illinois 60612
Kansas University Medical Center Kansas City Kansas 66160
Johns Hopkins University Hospital Baltimore Maryland 21287
Robert Wood Johnson University Hospital New Brunswick New Jersey 08901
Albany Medical Center Albany New York 12208
New York University Langone Medical Center - Tisch Hospital New York New York 10016
Mount Sinai Hospital New York New York 10019
The Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State Medical Columbus Ohio 43210
Oregon Health and Science University, Department of Neurology Portland Oregon 97239
St. Luke's Hospital & Health Network Bethlehem Pennsylvania 18015
Pennsylvania Hospital Philadelphia Pennsylvania 19107
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Allegheny General Hospital - ASRI Pittsburgh Pennsylvania 15212
Neurology Consultants of Dallas Dallas Texas 75251
CHI St. Luke's Health Baylor College of Medicine Medical Center Houston Texas 77030
Abbott, Medical and Clinical Affairs Plano Texas 75024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02989610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2024 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02989610 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →